Literature DB >> 15350944

The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.

David R Fogelman1, Johnson Chen, John A Chabot, John D Allendorf, Beth A Schrope, Ronald D Ennis, Stephen M Schreibman, Robert L Fine.   

Abstract

This article reviews the relevant literature and reports on The Columbia University Medical Center experience with chemoradiation for pancreatic cancer.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15350944     DOI： 10.1016/j.soc.2004.06.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  5 in total

1.  Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer.

Authors:  Michael D Chuong; Tom J Hayman; Manish R Patel; Mark S Russell; Mokenge P Malafa; Pamela J Hodul; Gregory M Springett; Junsung Choi; Ravi Shridhar; Sarah E Hoffe
Journal:  Gastrointest Cancer Res       Date:  2011-07

2.  Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma.

Authors:  R Krempien; M W Muenter; W Harms; J Debus
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

Authors:  John D Allendorf; Margaret Lauerman; Aliye Bill; Mary DiGiorgi; Nicole Goetz; Efsevia Vakiani; Helen Remotti; Beth Schrope; William Sherman; Michael Hall; Robert L Fine; John A Chabot
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

4.  Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Authors:  John A Chabot; Wei-Yann Tsai; Robert L Fine; Chunxia Chen; Carolyn K Kumah; Karen A Antman; Victor R Grann
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

5.  Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients.

Authors:  Ali A Siddiqui; Vaibhav Mehendiratta; David Loren; Thomas Kowalski; John Fang; Kristen Hilden; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2012-11-21       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.